文献速递乳腺乳腺X线

对比增强能谱乳腺摄影、数字乳腺摄影与数字乳腺断层合成的剂量比较

Comparative Dose of Contrast-Enhanced Spectral Mammography (CESM), Digital Mammography, and Digital Breast Tomosynthesis.
PubMed 文献 · AJR Am J Roentgenol · 2018-07-31

该研究利用体模和45例患者数据,采用欧洲与国际原子能机构认可的剂量学方案,比较两种设备五种成像模式的平均腺体剂量。结果显示系统1 CESM剂量为系统1 2D的1.8倍,为系统2 2D和3D的1.2倍,比系统2 2D加3D低0.6倍。结论认为系统1 CESM剂量在可接受范围内,不应妨碍其作为诊断性乳腺成像工具使用。

要点

  • 系统1 CESM的AGD是系统1 2D的1.8倍(p<0.001)。
  • 系统1 CESM的AGD是系统2 2D和3D的1.2倍(p<0.001)。
  • 系统1 CESM的AGD比系统2 2D加3D低0.6倍(p<0.001)。

核心结论

  • 系统1的CESM剂量与其他常用乳腺摄影检查相比处于可接受范围,不应妨碍其作为诊断性乳腺成像工具使用。

研究设计与样本

  • 回顾性剂量估算研究,纳入45例患者共180个视图,使用两种设备(系统1和系统2)的体模与患者数据,涵盖2D、3D和CESM五种成像模式,采用欧洲和国际原子能机构认可的剂量学方案估算平均腺体剂量(AGD),并用配对t检验及Bonferroni校正进行比较。

诊断标准与关键数值

  • 体模数据显示AGD从低到高依次为系统1 2D、系统2 2D与系统2 3D(两者相当,p=0.6)、系统1 CESM、系统2 2D加3D;患者数据中系统1 CESM的AGD为系统1 2D的1.8倍(p<0.001),为系统2 2D的1.2倍(p<0.001),为系统2 3D的1.2倍(p<0.001),比系统2 2D加3D低0.6倍(p<0.001)。

临床应用与阅片要点

  • 原文结论认为系统1的CESM剂量处于可接受范围,不应妨碍其作为诊断性乳腺成像工具使用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to provide a more accurate estimation of the radiation dose of contrast-enhanced spectral mammography (CESM) relative to that of 2D digital mammography and tomosynthesis using phantom and patient data and an accepted dosimetry protocol that eliminates vendor-specific average glandular dose (AGD) estimates while including breast density.

MATERIALS AND METHODS: Patient and phantom AGD estimation was performed using two vendors (system 1 and system 2) in five imaging modes, including 2D, 3D, and CESM imaging. Patient AGD was retrospectively estimated from 45 patients who underwent mammography with all imaging modes during 2012-2016. Patient and phantom AGD were estimated using accepted European and International Atomic Energy Agency protocols for dosimetry and were compared across imaging modes using a paired t test with Bonferroni correction.

RESULTS: Phantom data showed that the imaging modes with the lowest to highest AGDs were system 1 2D, followed by system 2 2D and system 2 3D, which had comparable values (p = 0.6), followed by system 1 CESM, and then by system 2 2D plus 3D. One hundred eighty views in 45 patients showed that the system 1 CESM AGD was 1.8 times greater than the system 1 2D AGD (p < 0.001), 1.2 times greater than the system 2 2D AGD (p < 0.001), 1.2 times greater than the system 2 3D AGD (p < 0.001), and 0.6 times less than the system 2 2D plus 3D AGD (p < 0.001).

CONCLUSION: The CESM dose for system 1 is within an acceptable range as compared with other commonly performed mammographic examinations and should not preclude its use as a diagnostic breast imaging tool.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Phillips J, Mihai G, Hassonjee SE, et al. Comparative Dose of Contrast-Enhanced Spectral Mammography (CESM), Digital Mammography, and Digital Breast Tomosynthesis. AJR Am J Roentgenol. 2018. PMID: 30063367. doi:10.2214/AJR.17.19036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。